FI860350A0 - Framstaellningsfoerfarande av gamma-globulin som laempar sig foer intravenoest ingivande. - Google Patents

Framstaellningsfoerfarande av gamma-globulin som laempar sig foer intravenoest ingivande.

Info

Publication number
FI860350A0
FI860350A0 FI860350A FI860350A FI860350A0 FI 860350 A0 FI860350 A0 FI 860350A0 FI 860350 A FI860350 A FI 860350A FI 860350 A FI860350 A FI 860350A FI 860350 A0 FI860350 A0 FI 860350A0
Authority
FI
Finland
Prior art keywords
globulin
gamma
concn
intravenoest
ingivande
Prior art date
Application number
FI860350A
Other languages
English (en)
Other versions
FI84136C (fi
FI860350A (fi
FI84136B (fi
Inventor
Juergen-Dietrich Fried Fiechtl
Bernhard Kerner
Juergen Holzapfel
Martin Puschmann
Tokusuke Kimura
Fumio Kurosu
Hans-Karsten Werner
Original Assignee
Woelm Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Woelm Pharma Gmbh & Co filed Critical Woelm Pharma Gmbh & Co
Publication of FI860350A publication Critical patent/FI860350A/fi
Publication of FI860350A0 publication Critical patent/FI860350A0/fi
Application granted granted Critical
Publication of FI84136B publication Critical patent/FI84136B/fi
Publication of FI84136C publication Critical patent/FI84136C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI860350A 1984-07-07 1986-01-24 Foerfarande foer framstaellning av gamma-globulin vilket laempar sig foer intravenoest administration. FI84136C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP84107985 1984-07-07
EP84107985A EP0168506B2 (en) 1984-07-07 1984-07-07 Process for preparing gamma globulin suitable for intravenous administration
EP8500320 1985-07-03
PCT/EP1985/000320 WO1986000530A1 (en) 1984-07-07 1985-07-03 Process for preparing gamma globulin suitable for intravenous administration
JP26362295 1995-09-19
JP7263622A JPH08319241A (ja) 1984-07-07 1995-09-19 静脈注射用ガンマグロブリン組成物

Publications (4)

Publication Number Publication Date
FI860350A FI860350A (fi) 1986-01-24
FI860350A0 true FI860350A0 (fi) 1986-01-24
FI84136B FI84136B (fi) 1991-07-15
FI84136C FI84136C (fi) 1991-10-25

Family

ID=26091956

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860350A FI84136C (fi) 1984-07-07 1986-01-24 Foerfarande foer framstaellning av gamma-globulin vilket laempar sig foer intravenoest administration.

Country Status (8)

Country Link
EP (1) EP0168506B2 (fi)
JP (2) JPH0816065B2 (fi)
AT (1) ATE59144T1 (fi)
DE (1) DE3483784D1 (fi)
DK (1) DK164023C (fi)
FI (1) FI84136C (fi)
NO (1) NO168943C (fi)
WO (1) WO1986000530A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
EP3088412B1 (en) * 2001-03-09 2021-05-05 Chugai Seiyaku Kabushiki Kaisha Protein purification method
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
AR087953A1 (es) 2011-08-26 2014-04-30 Baxter Int Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
JPS5732228A (en) * 1980-08-05 1982-02-20 Green Cross Corp:The Preparation of immunoglobulin usable for intravenous injection
JPS57203017A (en) * 1981-06-09 1982-12-13 Fujirebio Inc Purifying method of immunoglobulin
EP0078331B1 (en) * 1981-10-29 1986-01-29 Green Cross Corporation Process for preparing immunoglobulin suitable for intravenous injection

Also Published As

Publication number Publication date
NO168943C (no) 1992-04-22
ATE59144T1 (de) 1991-01-15
FI84136C (fi) 1991-10-25
DK164023B (da) 1992-05-04
EP0168506B1 (en) 1990-12-19
DK97286D0 (da) 1986-03-04
FI860350A (fi) 1986-01-24
JPS61500972A (ja) 1986-05-15
DE3483784D1 (de) 1991-01-31
EP0168506A1 (en) 1986-01-22
WO1986000530A1 (en) 1986-01-30
JPH0816065B2 (ja) 1996-02-21
FI84136B (fi) 1991-07-15
EP0168506B2 (en) 1998-01-07
DK164023C (da) 1992-09-28
NO860848L (no) 1986-03-06
JPH08319241A (ja) 1996-12-03
DK97286A (da) 1986-03-04
NO168943B (no) 1992-01-13

Similar Documents

Publication Publication Date Title
Miller et al. Liver injury, liver protection, and sulfur metabolism: methionine protects against chloroform liver injury even when given after anesthesia
SE8402551L (sv) Cinnamoylmoranolin-derivat
DE3872372D1 (de) Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
TR199700574T1 (xx) Molek�ler �aperon �retiminin haz�rlanmas� i�in yararl� hidroksilamin t�revleri ve bu t�revlerin haz�rlanmas�.
DK0656348T3 (da) Eddikesyrederivater som medikamenter
DK304682A (da) Vandholdigt topisk praeparat og fremgangsmaade til formindskelse af vandtab fra saadanne praeparater
SE7514388L (sv) Forfarande for att forbettra gammaglobuliners introvenostolerans
FI860350A0 (fi) Framstaellningsfoerfarande av gamma-globulin som laempar sig foer intravenoest ingivande.
FI844557L (fi) Koncentrat av antihemofilfaktorn viii och foerfarande foer framstaellning av detsamma.
GB1495289A (en) Pharmaceutically active proteinaceous compounds
FI854179L (fi) Antibakterieblandning och framstaellningsfoerfarande foer dess aktiva aemnen.
ATE59554T1 (de) Auf mercaptoethansulfonsaeuren basierende pharmazeutische zusammensetzungen, organische abkoemmlinge von mercaptoethansulfonsaeuren sowie verfahren zu deren herstellung.
GB1526617A (en) 2 and 3-substituted enkephalins
GB1526205A (en) Treatment of interferon-like material
Welsh et al. Heat-shock treatment of mouse pancreatic islets results in a partial loss of islet cells but no remaining functional impairment among the surviving β cells
ATE44750T1 (de) Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats.
Lowenthal et al. The Inhibition of Hyaluronidase by Sodium Salicylate and Its Possible Metabolites
Foá-Tomasi et al. Enhanced inhibition of RNA synthesis by amanitins in in vitro cultured cells
GB1159548A (en) Surgical Adhesives
SU1676628A1 (ru) Противоалкогольное средство "Гликал
Nellas et al. Pancreatic collagenase therapy for severe, progressive systemic sclerosis: Effect on skin and on hydroxyproline content in urine
Eckhardt et al. MEASUREMENT OF ELASTASE-INDUCED FIBRINOGEN-DERIVED PEPTIDES IN VITRO
Boogaerts et al. ERYTHROCYTES (RBC) AS SUICIDAL ENDOGENOUS SCAVENGERS IN IMMUNE TRIGGERED GRANULOCYTE (PMN) MEDIATED VASCULAR DAMAGE
Breviario et al. INHIBITION BY AD6 (8-MONOCHLORO-3-BETA-DIETHYLAMINOETHYL-4-METHYL-7-ETHOXY CARBONYL METHOXY COUMARIN) OF POLYMORPHONUCLEAR LEUKOCYTES ADHESION TO ENDOTHELIAL CELLS
TANAKA Studies on the Influences of Vitamins on Uric Acid Formation in Seminal Vesicles Report 1. Influences of Vitamin E on Uric Acid Formation

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: ARMOUR PHARMA GMBH